Skip to main
ADNT
ADNT logo

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 63%
Sell 13%
Strong Sell 0%

Bulls say

Adient is a leading seating supplier in the automotive industry, holding approximately a midteens share of the global market, including significant unconsolidated joint venture revenue of $3.5 billion in fiscal 2025. The company is poised to capture additional market share through onshored production initiatives and targeted gains from reshored programs, which could potentially more than double current expectations. Furthermore, management anticipates margin expansion to reach between 5.0% and 5.5% over the next 2-3 years, reflecting positive financial momentum and operational improvements.

Bears say

Adient is facing significant challenges due to its legacy issues, specifically loss-making metals contracts and uncompetitive plants that have persisted since its spin-off, adversely affecting profitability and cash flow. The company also contends with declining vehicle production in the EMEA region, influenced by an unfavorable production mix, which is further exacerbated by persistent geopolitical and macroeconomic headwinds. As a result, these factors collectively contribute to a negative outlook on Adient's financial performance and market position.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 63% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.